五种主要气流受限标准识别慢阻肺高危人群的比较:一项当代人群队列研究
该研究在一般人群中随机纳入108 246名20-100岁个体,随访2003至2018年,头对头比较GOLD(FEV1/FVC<0.70)与四种LLN标准诊断气流受限在识别慢阻肺急性加重与死亡风险上的差异。结果显示气流受限患病率为8.2%-17%,五种标准识别出的个体在急性加重与死亡风险上相似,LLN标准在死亡结局上的Harrell's C略高。
要点
- 五种气流受限标准患病率差异大(8.2%-17%),但识别出的高危个体风险相似。
- GOLD标准急性加重HR为17(95%CI 14-20),LLN标准为18-21。
- LLN标准在死亡结局上的Harrell's C略高于GOLD标准。
核心结论
- 五种标准诊断气流受限的患病率差异明显,但识别出的个体慢阻肺急性加重与死亡风险相似。
- LLN标准在死亡结局上的Harrell's C略高于GOLD标准。
研究设计与样本
- 基于一般人群的当代队列研究,随机纳入108 246名20-100岁个体。
- 随访自2003年至2018年,中位随访14.4年,评估慢阻肺急性加重、呼吸死亡与全因死亡风险。
- 比较GOLD(FEV1/FVC<0.70)与GLI、NHANES、ECSC、CCHS/CGPS四种LLN标准。
主要发现
- 气流受限患病率:GOLD 17%、GLI 8.6%、NHANES 10%、ECSC 8.2%、CCHS/CGPS 14%。
- 随访期间观察到2745例慢阻肺急性加重、762例呼吸死亡和10 338例全因死亡。
- 急性加重HR:GOLD 17(95%CI 14-20)、GLI 21(18-24)、NHANES 20(17-23)、ECSC 21(18-24)、CCHS/CGPS 18(16-21)。
- 呼吸死亡HR:GOLD 3.7(3.1-4.3)、GLI 6.4(5.6-7.5)、NHANES 5.7(4.9-6.6)、ECSC 6.2(5.3-7.2)、CCHS/CGPS 4.5(3.9-5.2)。
- 全因死亡HR:GOLD 1.5(1.4-1.5)、GLI 1.9(1.8-2.0)、NHANES 1.8(1.7-1.9)、ECSC 1.9(1.8-2.0)、CCHS/CGPS 1.7(1.6-1.7)。
关键数值与推荐
- GOLD标准为FEV1/FVC<0.70,四种LLN标准为FEV1/FVC<LLN。
- LLN方程分别来自GLI、NHANES、ECSC和CCHS/CGPS。
- Harrell's C在各结局间差异微小,但LLN标准在死亡结局上略高于GOLD。
临床怎么用
- 临床诊断气流受限时,GOLD与LLN标准均可识别慢阻肺高危个体。
- 不同标准患病率差异大,解读患病率数据时需注明所用标准。
- 选择标准时可结合对死亡风险的判别能力考虑LLN标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Different airflow limitation criteria are often used to diagnose COPD. We investigated head-to-head whether Global Initiative for Chronic Obstructive Lung Disease (GOLD) (FEV1/FVC <0.70) and four lower limit of normal (LLN) (FEV1/FVC <LLN) criteria to diagnose airflow limitation differ in identifying individuals at risk of COPD exacerbations and mortality. METHODS: 108 246 individuals aged 20-100 years randomly selected from the general population were followed from 2003 through 2018 to determine risk of COPD exacerbations, respiratory mortality and all-cause mortality. LLN criteria used equations from Global Lung Initiative (GLI), National Health and Nutrition Examination Survey (NHANES), European Community for Steel and Coal (ECSC) and Copenhagen City Heart Study (CCHS)/Copenhagen General Population Study (CGPS). RESULTS: Prevalence of airflow limitation was 17% for GOLD, 8.6% for GLI, 10% for NHANES, 8.2% for ECSC and 14% for CCHS/CGPS. During 14.4 years follow-up, we observed 2745 COPD exacerbations, 762 respiratory deaths and 10 338 all-cause deaths. Comparing individuals with versus without airflow limitation, HRs for COPD exacerbations were 17 (95% CI 14 to 20) for GOLD, 21 (18 to 24) for GLI, 20 (17 to 23) for NHANES, 21 (18 to 24) for ECSC and 18 (16 to 21) for CCHS/CGPS. Corresponding HRs for respiratory mortality were 3.7 (3.1 to 4.3), 6.4 (5.6 to 7.5), 5.7 (4.9 to 6.6), 6.2 (5.3 to 7.2) and 4.5 (3.9 to 5.2), and for all-cause mortality 1.5 (1.4 to 1.5), 1.9 (1.8 to 2.0), 1.8 (1.7 to 1.9), 1.9 (1.8 to 2.0) and 1.7 (1.6 to 1.7), respectively. Differences in Harrell's C were minute for these outcomes; nonetheless, Harrell's C was slightly higher for LLN criteria compared with GOLD for mortality outcomes. CONCLUSIONS: The prevalence of airflow limitation ranged from 8% to 17% using GOLD and four different LLN criteria; however, identified individuals with the five different criteria had similar risk of COPD exacerbations and mortality.
引用
- Çolak Y, Nordestgaard BG, Vestbo J, et al. Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort. Thorax. 2020. PMID: 32820083. doi:10.1136/thoraxjnl-2020-214559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。